IDEAS home Printed from https://ideas.repec.org/a/eee/ehbiol/v1y2003i2p259-266.html
   My bibliography  Save this article

The effect of new drug approvals on HIV mortality in the US, 1987-1998

Author

Listed:
  • Lichtenberg, Frank R.

Abstract

No abstract is available for this item.

Suggested Citation

  • Lichtenberg, Frank R., 2003. "The effect of new drug approvals on HIV mortality in the US, 1987-1998," Economics & Human Biology, Elsevier, vol. 1(2), pages 259-266, June.
    • Handle: RePEc:eee:ehbiol:v:1:y:2003:i:2:p:259-266
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S1570-677X(02)00031-X
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Carol Corrado & John Haltiwanger & Daniel Sichel, 2005. "Measuring Capital in the New Economy," NBER Books, National Bureau of Economic Research, Inc, number corr05-1.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Aburto, José Manuel & Kristensen, Frederikke Frehr & Sharp, Paul, 2021. "Black-white disparities during an epidemic: Life expectancy and lifespan disparity in the US, 1980–2000," Economics & Human Biology, Elsevier, vol. 40(C).
    2. Wilson, Nicholas, 2016. "Antiretroviral therapy and demand for HIV testing: Evidence from Zambia," Economics & Human Biology, Elsevier, vol. 21(C), pages 221-240.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Qing Li & Long Hai Vo, 2021. "Intangible Capital and Innovation: An Empirical Analysis of Vietnamese Enterprises," Economics Discussion / Working Papers 21-02, The University of Western Australia, Department of Economics.
    2. Anmol Bhandari & Ellen R. McGrattan, 2017. "Sweat Equity in U.S. Private Business," Staff Report 560, Federal Reserve Bank of Minneapolis.
    3. Toma Lankauskiene, 2021. "Labour Productivity Growth Determinants in the Manufacturing Sector in the Baltic States," ConScienS Conference Proceedings 025tl, Research Association for Interdisciplinary Studies.
    4. Ryan A. Decker & Pablo N. D'Erasmo & Hernan Moscoso Boedo, 2016. "Market Exposure and Endogenous Firm Volatility over the Business Cycle," American Economic Journal: Macroeconomics, American Economic Association, vol. 8(1), pages 148-198, January.
    5. Joel M. David & François Gourio, 2023. "The Rise of Intangible Investment and the Transmission of Monetary Policy," Chicago Fed Letter, Federal Reserve Bank of Chicago, vol. 0, pages 1-8, August.
    6. Felix Roth & Anna-Elisabeth Thum, 2022. "Intangible Capital and Labor Productivity Growth: Panel Evidence for the EU from 1998–2005," Contributions to Economics, in: Intangible Capital and Growth, chapter 0, pages 101-128, Springer.
    7. De, Supriyo, 2014. "Intangible capital and growth in the ‘new economy’: Implications of a multi-sector endogenous growth model," Structural Change and Economic Dynamics, Elsevier, vol. 28(C), pages 25-42.
    8. Lisa Evers & Helen Miller & Christoph Spengel, 2015. "Intellectual property box regimes: effective tax rates and tax policy considerations," International Tax and Public Finance, Springer;International Institute of Public Finance, vol. 22(3), pages 502-530, June.
    9. Corrado Carol & Lengermann Paul & Beaulieu J. Joseph & Bartelsman Eric J., 2007. "Sectoral Productivity in the United States: Recent Developments and the Role of IT," German Economic Review, De Gruyter, vol. 8(2), pages 188-210, May.
    10. Marek Kapička, 2012. "How Important Is Technology Capital for the United States?," American Economic Journal: Macroeconomics, American Economic Association, vol. 4(2), pages 218-248, April.
    11. Derya Fındık & Aysıt Tansel, 2013. "Intangible investment and Technical efficiency: The case of software-intensive manufacturing firms in Turkey," EY International Congress on Economics I (EYC2013), October 24-25, 2013, Ankara, Turkey 235, Ekonomik Yaklasim Association.
    12. Edquist, Harald, 2009. "How Much does Sweden Invest in Intangible Assets?," Working Paper Series 785, Research Institute of Industrial Economics.
    13. Nikulainen, Tuomo & Pajarinen, Mika, 2013. "Industry restructuring in the ICT sector – What does labor mobility tell us about skill relatedness and knowledge spillovers?," ETLA Working Papers 17, The Research Institute of the Finnish Economy.
    14. Fernando Galindo-Rueda, 2013. "The OECD measurement agenda for innovation," Chapters, in: Fred Gault (ed.), Handbook of Innovation Indicators and Measurement, chapter 9, pages 217-246, Edward Elgar Publishing.
    15. Jeon, Heesang, 2015. "Knowledge and Contemporary Capitalism in Light of Marx's Value Theory," Thesis Commons g5njk, Center for Open Science.
    16. Haskel, Jonathan & Wallis, Gavin, 2013. "Public support for innovation, intangible investment and productivity growth in the UK market sector," Economics Letters, Elsevier, vol. 119(2), pages 195-198.
    17. Cecilia Jona Lasinio & Stefano Manzocchi & Valentina Meliciani, 2016. "Intangible Assets and Participation in Global Value Chains: An Analysis on a Sample of European Countries," Working Papers LuissLab 16129, Dipartimento di Economia e Finanza, LUISS Guido Carli.
    18. Breithaupt, Patrick & Kesler, Reinhold & Niebel, Thomas & Rammer, Christian, 2020. "Intangible capital indicators based on web scraping of social media," ZEW Discussion Papers 20-046, ZEW - Leibniz Centre for European Economic Research.
    19. Chiara Criscuolo & Angelo Secchi, 2016. "Resources (mis)allocation, innovation and the competitiveness of Europe," Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 43(1), pages 1-9, March.
    20. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:ehbiol:v:1:y:2003:i:2:p:259-266. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/inca/622964 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.